share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Hoch Lynelle

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施贵宝 | 4：持股变动声明
SEC announcement ·  03/12 20:04
Moomoo AI 已提取核心信息
On March 10, 2024, Lynelle Hoch, President of Cell Therapy Org. at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Hoch acquired a total of 4,351 shares through the exercise of derivative securities at no cost. On the same day, Hoch disposed of 2,625 shares through various transactions, including the payment of exercise price or tax liability by delivering or withholding securities, with some shares sold at a price of $53.79 each. The total market value of the disposed shares amounted to $70,357.32. After these transactions, Hoch's direct holdings in Bristol-Myers Squibb common stock amounted to 1,726 shares.
On March 10, 2024, Lynelle Hoch, President of Cell Therapy Org. at Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock. Hoch acquired a total of 4,351 shares through the exercise of derivative securities at no cost. On the same day, Hoch disposed of 2,625 shares through various transactions, including the payment of exercise price or tax liability by delivering or withholding securities, with some shares sold at a price of $53.79 each. The total market value of the disposed shares amounted to $70,357.32. After these transactions, Hoch's direct holdings in Bristol-Myers Squibb common stock amounted to 1,726 shares.
2024年3月10日，百时美施贵宝（BMY）细胞疗法组织总裁莱内尔·霍赫完成了一系列涉及该公司普通股的交易。霍赫通过免费行使衍生证券，共收购了4,351股股票。同一天，霍赫通过各种交易出售了2625股股票，包括通过交付或预扣证券来支付行使价或纳税义务，其中一些股票以每股53.79美元的价格出售。已处置股份的总市值为70,357.32美元。在这些交易之后，霍赫直接持有的百时美施贵宝普通股为1,726股。
2024年3月10日，百时美施贵宝（BMY）细胞疗法组织总裁莱内尔·霍赫完成了一系列涉及该公司普通股的交易。霍赫通过免费行使衍生证券，共收购了4,351股股票。同一天，霍赫通过各种交易出售了2625股股票，包括通过交付或预扣证券来支付行使价或纳税义务，其中一些股票以每股53.79美元的价格出售。已处置股份的总市值为70,357.32美元。在这些交易之后，霍赫直接持有的百时美施贵宝普通股为1,726股。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息